The GWAS data confirmed that the variants in the 6 COPD-hub genes (IRAK2, MECOM, CDC42BPA, ASB4, DPF3 and TMEM67) shows genome wide significant association to traits that could potentially modify the risk of COPD pathology development. Here, CDC42BPA is linked to chronic obstructive pulmonary disease.